The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.
Normal saline and Ringer's solutions are the preferred crystalloid fluids administered in early septic shock. However, evidence have associated saline with hyperchloremia and secondary metabolic acidosis, and renal vasoconstriction, increased incidence of acute kidney injury (AKI) and mortality. The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
2,000
Use the choice of crystalloid for resuscitation during the first 72 hours after enrollment
Incidence of major adverse renal events in 28 days
Incidence of major adverse renal events
Time frame: 28 day
Incidence of kidney injury
Incidence of kidney injury
Time frame: 28 day
Serum creatinine(umol/L)
serum creatinine(umol/L)
Time frame: 28 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.